The Latest
-
China Says Worst of Flooding Still to Come as Situation ‘Severe’
-
Moderna Receives Additional $472 Million from BARDA for COVID-19 Vaccine; Target Price $90
-
‘McRefugees’ lose restaurant shelter as Hong Kong battles third wave of Covid-19 cases
-
AstraZeneca bets up to $6 billion on new Daiichi cancer drug